Monocytes-neutrophils-ratio as predictive marker for failure of first induction therapy in AML

ConclusionsWe propose a novel and non-invasive method for detection of failure of first induction therapy in patients with de novo AML and “7 + 3” induction therapy. The MNR is free of cost since the required cell counts are performed routinely for each patient undergoing intensive chemotherapy.
Source: Blood Cells, Molecules, and Diseases - Category: Hematology Source Type: research